179056-98-5

Basic information

• Product Name: CHEMPACIFIC 38112
• Synonyms: CHEMPACIFIC 38112;2,4-DICHLORO-6-METHYL-PYRIDIN-3-YLAMINE;2,4-DICHLORO-6-METHYLPYRIDIN-3-AMINE;3-PyridinaMine, 2,4-dichloro-6-Methyl-
• CAS NO: 179056-98-5
• Molecular Formula: C₆H₆Cl₂N₂
• Molecular Weight: 177.03
• EINECS: 200-258-5
• Mol File: 179056-98-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 271.975 °C at 760 mmHg
• Flash Point: 118.286 °C
• Appearance: /
• Density: 1.415 g/cm³
• Storage Temp.: 2-8°C
• CAS DataBase Reference: CHEMPACIFIC 38112(CAS DataBase Reference)
• NIST Chemistry Reference: CHEMPACIFIC 38112(179056-98-5)
• EPA Substance Registry System: CHEMPACIFIC 38112(179056-98-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 179056-98-5(Hazardous Substances Data)

Usage

General Description

CHEMPACIFIC 38112 is a chemical compound that serves as a highly effective antifouling agent for marine applications. It is designed to prevent the formation and growth of marine organisms on surfaces such as ship hulls, underwater structures, and equipment. CHEMPACIFIC 38112 is based on a non-toxic and biodegradable chemistry, making it environmentally friendly and safe for marine ecosystems. Additionally, CHEMPACIFIC 38112 is formulated to provide long-lasting protection against fouling, reducing the need for frequent maintenance and cleaning. Overall, this chemical compound offers a reliable and sustainable solution for preventing marine biofouling.

Upstream product

• 63897-12-1 2,4-dichloro-6-methyl-3-nitropyridine 
• 5975-12-2 2,4-dichloro-3-nitro-pyridine 
• 89282-12-2 2,4-dihydroxy-3-nitropyridine 
• 173772-63-9 2,4-dichloropyridin-3-ylamine 
• 626-03-9 3-deazauracil 
• 13061-96-6 dihydroxy-methyl-borane 
• 237435-16-4 6-bromo-2,4-dichloropyridin-3-ylamine 

Downstream Products

• 179056-99-6 phenyl N-<2,4-dichloro-6-methylpyridin-3-yl>carbamate 
• 237435-17-5 3-amino-4-chloro-6-methyl-2-(2-phenylethynyl)pyridine 

Relevant articles and documents

1-(HET)ARYLSULFONYL-(PYRROLIDINE OR PIPERIDINE)-2-CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS

The invention is concerned with the compounds of formula I and salts thereof and other compounds of formulas II-IX as disclosed herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formulas I-IX as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain or asthma.

Compounds and methods which modulate feeding behavior and related diseases

There are provided compounds, compositions and methods of use thereof in the modulation of feeding behavior, obesity, diabetes, cancer (tumor), inflammatory disorders, depression, stress related disorders, Alzheimer's disease and other disease conditions.

Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 3. Discovery of a novel series of N-alkyl-N-[(fluorophenoxy)benzyl]-N'-arylureas with weak toxicological effects on adrenal glands

A series of N-alkyl-N-[(fluorophenoxy)benzyl]-N'-arylureas were prepared and evaluated for their ability to inhibit intestinal acyl-CoA:cholesterol O- acyltransferase and to inhibit accumulation of cholesteryl esters in macrophages in vitro. In vivo hypocholesterolemic activity was assessed in cholesterol-fed rats by oral administration as a dietary admixture and/or by gavage in a PEG400 vehicle. Modification of the alkyl substituent on the N'- aryl moiety and on the urea nitrogen significantly influenced macrophage assay in vitro. Toxicological study revealed a distinct relationship between macrophage assay and the toxicity observed in adrenal glands of rabbits treated with representatives of this series of compounds. Investigations utilizing the macrophage assay as an indicator for adrenal toxicity led to the identification of compounds 1g (FR190809) and 1k (FR186485, or FR195249 as its hydrochloride salt) as potent, nonadrenotoxic, orally efficacious ACAT inhibitors irrespective of the administration method.